| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Enterococcus faecium (D3AP9 + vancomycin-resistant) |
- |
- |
1.2 － ? |
RU79115  |
33 |
| Enterococcus faecium (D3AP9 + vancomycin-resistant) |
- |
- |
>40 － ? |
Vancomycin (Vancocyn, Lyphocin) |
33 |
| Enterococcus faecium (D3AP9c + vancomycin-resistant) |
- |
- |
1.2 － ? |
Eperezolid (PNU-100592) |
11 |
| Enterococcus faecium (D3HM3 + vancomycin-resistant) |
- |
- |
0.08 － ? |
RU79115 |
33 |
| Enterococcus faecium (D3HM3 + vancomycin-resistant) |
- |
- |
>40 － ? |
Vancomycin (Vancocyn, Lyphocin) |
33 |
| Enterococcus faecium (D3HM4 + vancomycin-resistant) |
- |
- |
0.3 － ? |
Eperezolid (PNU-100592) |
11 |
| Enterococcus faecium (D3HM4 + vancomycin-resistant) |
- |
- |
0.3 － ? |
RU79115 |
33 |
| Enterococcus faecium (D3HM4 + vancomycin-resistant) |
- |
- |
>40 － ? |
Vancomycin (Vancocyn, Lyphocin) |
33 |
| Enterococcus faecium (D3HT12 + vancomycin-resistant) |
- |
- |
0.3 － ? |
Eperezolid (PNU-100592) |
11 |
| Enterococcus faecium (D3HT12 + vancomycin-resistant) |
- |
- |
0.3 － ? |
RU79115 |
33 |
| Enterococcus faecium (D3HT12 + vancomycin-resistant) |
- |
- |
>40 － ? |
Vancomycin (Vancocyn, Lyphocin) |
33 |
| Enterococcus faecium (D3HT7) |
- |
0.15 |
? － ? |
RU79115 |
33 |
| Enterococcus faecium (D3HT7) |
- |
- |
0.6 － ? |
Eperezolid (PNU-100592) |
11 |
| Enterococcus faecium (D3HT7) |
- |
- |
2.5 － ? |
Vancomycin (Vancocyn, Lyphocin) |
33 |
| Enterococcus faecium (EF-12 + vancomycin-resistant clinical isolate) |
- |
- |
0.8 － ? |
OSU 8 |
276 |
| Enterococcus faecium (EF-12 + vancomycin-resistant clinical isolate) |
- |
- |
1.5 － ? |
OSU 259 |
276 |
| Enterococcus faecium (EF-12 + vancomycin-resistant clinical isolate) |
- |
- |
1.5 － ? |
OSU 95 |
276 |
| Enterococcus faecium (EF-12 + vancomycin-resistant clinical isolate) |
- |
- |
1.5 － ? |
OSU 99 |
276 |
| Enterococcus faecium (EF-12 + vancomycin-resistant clinical isolate) |
- |
- |
6.3 － ? |
OSU 199 |
276 |
| Enterococcus faecium (erythromycin-intermediate-susceptible) |
≤0.12 |
≤0.12 |
? － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-resistant) |
1 |
8 |
0.5 － 16 |
Quinupristin/Dalfopristin (Synercid) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-resistant) |
8 |
16 |
0.005 － 16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-resistant) |
8 |
16 |
0.007 － 16 |
HMR 3004 (RU 64004) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-resistant) |
>256 |
>256 |
0.06 － >256 |
Clindamycin (Cleocin) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-resistant) |
>512 |
>512 |
2 － >512 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-susceptible) |
1 |
8 |
0.5 － 16 |
Quinupristin/Dalfopristin (Synercid) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-susceptible) |
4 |
16 |
0.015 － 16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
448 |
| Enterococcus faecium (erythromycin-resistant + vancomycin-susceptible) |
8 |
16 |
0.015 － 16 |
HMR 3004 (RU 64004) |
448 |